Abstract
Background and AimsVitamin D deficiency is associated with increased vulnerability to respiratory infections. This study aimed to determine the potential relationships between coronavirus disease 2019 (COVID‐19) severity, serum vitamin D concentrations, and some inflammatory markers among pediatric COVID‐19 patients in Iran.MethodsA retrospective study was conducted among hospitalized pediatric COVID‐19 cases in Abuzar Hospital (Ahvaz, Iran) for 6 months. The COVID‐19 diagnosis was based on the real‐time reverse transcription‐polymerase chain reaction technique. Demographic and clinical data of patients were recorded. Patients with serum vitamin D levels lower than 20 ng/ml were assigned as Group 1 and those with serum vitamin D concentrations equal to or more than 20 ng/ml were considered as Group 2.ResultsA total of 144 patients were enrolled. Their mean age was 80 ± 49 months (range: 1–16 years). Patients in Group 1 had significantly lower levels of serum vitamin D, calcium, and lymphocytes, as well as higher fibrinogen, d‐dimer, and C‐reactive protein (CRP) levels compared with those in Group 2 (p < 0.001). In addition, they had a significantly higher dry cough, fever, chest radiographic findings, respiratory rate, and longer hospital length of stay than patients in Group 2. Serum concentrations of vitamin D were positively correlated with levels of serum calcium, lymphocytes, and neutrophils but negatively correlated with CRP, fibrinogen, and d‐dimer values. Furthermore, patients with moderate or severe courses of COVID‐19 had significantly higher inflammatory markers (CRP, d‐dimer, and fibrinogen), as well as lower levels of serum calcium, vitamin D, lymphocytes, and neutrophils than those with mild COVID‐19 (p < 0.001). In the multivariate analysis, fibrinogen level on admission was detected as the independent predictor of severe COVD‐19 (odds ratio = 1.06, 95% confidence interval: 1.03–1.09; p < 0.001).ConclusionThis study indicated associations between the severity of COVID‐19, serum vitamin D concentrations, and some inflammatory markers in pediatric COVID‐19 patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.